Skin science article

Tripeptide-29 vs Palmitoyl Tripeptide-1 — Peptide Comparison

At a Glance Quickcomparison Dose Range Tripeptide-29 0.5%–2% % Palmitoyl Tripeptide-1 0.5%–3% % Frequency Once daily Administration Topical Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Limited human trials Efficacy Benefitrat

By Peptide Skincare & Beauty Editorial TeamPublished May 23, 2026

At a Glance

Quickcomparison

Dose Range

Tripeptide-29

0.5%–2% %

Palmitoyl Tripeptide-1

0.5%–3% %

Frequency

Once daily

Administration

Topical

Cycle Length

Ongoing/indefinite

Onset Speed

Moderate (1-2 weeks)

Evidence Level

Limited human trials

Efficacy

Benefitratings

Collagen Synthesis

Anti-Photoaging

Skin Hydration

Collagen Production

Anti-Aging

Skin Firmness

Technical Data

Compoundspecifications

Molecular Formula

C12H19N3O5

Molecular Weight

285.3 Da

Half-Life

Oral: rapidly metabolized to Pro-Hyp; accumulates in skin tissue over hours; topical: sustained local activity

Bioavailability

4.4% absolute oral bioavailability; transporter-mediated intestinal absorption; preferential skin tissue accumulation

CAS Number

2239-67-0

C30H54N6O5

578.8 Da

Limited data; peptide is susceptible to enzymatic degradation in skin but palmitoylation improves stability compared to unmodified GHK

Enhanced topical penetration via palmitoyl lipid modification; reaches dermis where fibroblasts reside

147732-56-7

Protocols

Dosingtiers

standard

1,000-2,500 mg/day of Gly-Pro-Hyp-rich collagen tripeptide

8-12 weeks for measurable skin changes

Human trials of low-molecular-weight collagen peptide used 1,000 mg/day for 12 weeks, improving skin hydration, elasticity, and wrinkling [6]; higher-end practice extends to ~2,500 mg/day [6].

0.05-0.1% (roughly 500-1,000 ppm) in a leave-on serum or cream

Once or twice daily

Ongoing cosmetic use

Typical cosmetic leave-on use level for collagen-derived tripeptides; applied to clean skin as part of a daily routine [1].

starting

Under 10 ppm (<0.001%) in finished product

Ongoing

Customary leave-on cosmetic use is below 10 ppm of active peptide [6]. Pal-GHK is the signal-peptide core of the Matrixyl 3000 blend and is typically paired with Pal-GQPR.

Up to ~0.002% in finished product

Upper end of reported survey concentrations for leave-on products [6]. Even at this level the active peptide content is very low, which is normal for palmitoyl signal peptides.

Applications

Bestsuited for

Individuals seeking evidence-based collagen supplementation for skin health

Tripeptide-29 is particularly well-suited for individuals focused on individuals seeking evidence-based collagen supplementation for skin health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those with photoaged skin from chronic sun exposure

Tripeptide-29 is particularly well-suited for individuals focused on those with photoaged skin from chronic sun exposure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People wanting to support skin hydration and elasticity from both oral and topical routes

Tripeptide-29 is particularly well-suited for individuals focused on people wanting to support skin hydration and elasticity from both oral and topical routes. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy

Tripeptide-29 is particularly well-suited for individuals focused on users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Individuals seeking comprehensive collagen stimulation through topical skincare

Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on individuals seeking comprehensive collagen stimulation through topical skincare. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those with aging skin showing loss of firmness, elasticity, and density

Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on those with aging skin showing loss of firmness, elasticity, and density. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People looking for non-invasive alternatives to injectable collagen treatments

Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on people looking for non-invasive alternatives to injectable collagen treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those seeking GHK-based skin benefits without copper peptide formulation complexity

Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on those seeking ghk-based skin benefits without copper peptide formulation complexity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety Profile

Sideeffects

Common

Mild Gastrointestinal Adjustment

Aftertaste (oral)

Mild Skin Warmth (topical)

Initial Skin Purging

Uncommon

Allergic Sensitivity

Serious

Anaphylaxis (theoretical)

Limited Bioavailability and Potential Immunogenicity

Temporary Skin Irritation

Mild Redness

Dryness

Mild Peeling

Contact Dermatitis

Skin Sensitization from Fragmented Peptide

Research Status

Safety& evidence

FDA Status

Research compound

Safety Overview

Tripeptide-29 (Gly-Pro-Hyp, glycyl-prolyl-hydroxyproline) is a naturally occurring collagen-derived tripeptide with an excellent cosmetic safety profile. This is the fundamental repeat unit of collagen protein, making it highly biocompatible. Both oral and topical forms demonstrate minimal adverse effects in clinical trials. No serious adverse events have been reported in published clinical studies spanning over 15 years. The tripeptide is generally recognized as safe (GRAS) for both topical and oral use by regulatory authorities. Individual responses are generally benign and limited to mild gastrointestinal adjustment with oral supplementation or transient dermal warmth with topical application. The primary safety consideration is allergenicity in individuals with gelatin or collagen allergies, which is rare but requires awareness. Molecular weight (285.3 Da) ensures limited systemic absorption when applied topically.

Contraindications

xKnown allergy to collagen, gelatin, or animal-derived protein products

xActive skin infections or dermatitis at the topical application site

xHypersensitivity to hydroxyproline-containing peptides

xConcurrent use with products at extreme pH that may hydrolyze the peptide

Palmitoyl tripeptide-1 demonstrates excellent cosmetic safety with GRAS/safe-for-use designation in topical formulations at concentrations up to 2%. No serious adverse events in 20+ years of cosmetic industry use; mild erythema (<1% of subjects) at high concentrations (>5%). Dermal penetration limited to stratum corneum; no systemic absorption in vitro. Compatible with common skincare ingredients.

xKnown hypersensitivity to palmitoyl tripeptide-1 or related peptide ingredients

xActive skin infections or severely compromised skin barrier at application site

xOpen wounds or actively inflamed dermatitis in treatment area

xNo known systemic contraindications for topical cosmetic use

Decision Guide

Which isright for you?

Choose Tripeptide-29 if...